These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 7531290

  • 1. Effects of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance.
    Hamood M, Bluche PF, De Vroey C, Corazza F, Bujan W, Fondu P.
    Mycoses; 1994; 37(3-4):93-9. PubMed ID: 7531290
    [Abstract] [Full Text] [Related]

  • 2. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
    Misaki M, Ueyama Y, Tsukamoto G, Matsumura T.
    Br J Cancer; 1998 Mar; 77(6):884-9. PubMed ID: 9528829
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK, He XH, Yang S, Wang HQ, Jiang ZF, Zhu YZ, Ke XY, Zhang Y, Liu YP, Zhang WJ, Wang Z, Shi QZ, Xie XD, Zhang HL, Wang JJ, Luo DY, Zheng QS, Sun RY.
    Zhonghua Yi Xue Za Zhi; 2006 Dec 26; 86(48):3414-9. PubMed ID: 17313855
    [Abstract] [Full Text] [Related]

  • 4. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice.
    Matsuzaki G, Li XY, Ohyama Y, Nomoto K.
    Int J Immunopharmacol; 1996 Dec 26; 18(6-7):363-9. PubMed ID: 9024937
    [Abstract] [Full Text] [Related]

  • 5. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R, Gasper PW, Ogilvie GK, Boone TC, Dornsife RE.
    Exp Hematol; 1991 Sep 26; 19(8):759-67. PubMed ID: 1714401
    [Abstract] [Full Text] [Related]

  • 6. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K, Obuchi M, Watanabe M, Kusaka M, Seki M.
    Oncol Res; 1995 Sep 26; 7(3-4):165-71. PubMed ID: 8555650
    [Abstract] [Full Text] [Related]

  • 7. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
    Yoshida M.
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr 26; 83(4):518-27. PubMed ID: 1375670
    [Abstract] [Full Text] [Related]

  • 8. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
    Huang W, Liu J, Zeng Y, Wu F, Li N, Chen K, Hong Y, Wang L, Zhen H, Lin L.
    Cancer Chemother Pharmacol; 2018 Oct 26; 82(4):607-613. PubMed ID: 30043207
    [Abstract] [Full Text] [Related]

  • 9. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P, La Gamma EF.
    Pediatrics; 1997 Jul 26; 100(1):E6. PubMed ID: 9200380
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological effects of recombinant human granulocyte colony-stimulating factor modified by polyethylene glycol on anticancer drug-induced neutropenia in mice.
    Ishikawa M, Okada Y, Satake-Ishikawa R, Kakitani M, Kawagishi M, Matsuki S, Kusaka M, Asano K.
    Gen Pharmacol; 1994 May 26; 25(3):533-7. PubMed ID: 7523237
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ, Plard JP, Wells MY, Zerial A, Roquet F.
    Cancer Chemother Pharmacol; 1997 May 26; 39(3):259-66. PubMed ID: 8996530
    [Abstract] [Full Text] [Related]

  • 12. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun 26; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 26; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effect of granulocyte colony-stimulating factor and cephem antibiotics against experimental infections in neutropenic mice induced by cyclophosphamide.
    Wakiyama H, Tsuru S, Hata N, Shinomiya M, Shinomiya N, Noritake M, Umezawa Y, Rokutanda M.
    Clin Exp Immunol; 1993 May 26; 92(2):218-24. PubMed ID: 7683585
    [Abstract] [Full Text] [Related]

  • 15. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.
    Cairo MS, Plunkett JM, Mauss D, Van de ven C.
    Blood; 1990 Nov 01; 76(9):1788-94. PubMed ID: 1699622
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of recombinant human granulocyte-colony stimulating factor alone and in combination with antifungal agents against disseminated trichosporonosis in neutropenic mice.
    Perparim K, Hashimoto A, Nasu M.
    J Infect Chemother; 1996 Nov 01; 2(4):232-239. PubMed ID: 29681373
    [Abstract] [Full Text] [Related]

  • 17. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.
    Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, Williams B, Storb R, Thomas ED, Buckner CD.
    Blood; 1993 Apr 01; 81(7):1883-8. PubMed ID: 7681705
    [Abstract] [Full Text] [Related]

  • 18. Long survival of leukemic mice by repeated combination treatment of cyclophosphamide and recombinant human granulocyte colony-stimulating factor.
    Tamura M, Nomura H, Ono M, Bessho M, Hirashima K.
    Leukemia; 1991 Dec 01; 5(12):1043-9. PubMed ID: 1723131
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y, Mayumi H, Tomita Y, Eto M, Maeda T, Nomoto K.
    J Immunol; 1991 Apr 15; 146(8):2639-47. PubMed ID: 1707914
    [Abstract] [Full Text] [Related]

  • 20. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
    Opal SM, Jhung JW, Keith JC, Goldman SJ, Palardy JE, Parejo NA.
    Blood; 1999 May 15; 93(10):3467-72. PubMed ID: 10233899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.